Short-term use of painkiller drugs does not increase the risk of heart attack

NewsGuard 100/100 Score

Short-term use of painkiller drugs in the same family as ibuprofen does not increase the risk of having a heart attack.

The results of a large study, published in the open access journal BMC Medicine, confirm that taking traditional non-steroidal anti-inflammatory drugs (NSAIDs) in the recommended dose for less than a year does not increase the risk of having a heart attack. When taken regularly for more than one year, however, some traditional NSAIDs can slightly increase the risk of non-fatal heart attack. This does not apply to ibuprofen or naproxen, two of the most widely-used NSAIDs.

Luis A. García Rodríguez and Antonio González-Pérez from the Centro Español de Investigación Farmacoepidemiológica in Madrid, Spain, studied NSAID use in 4,975 patients who had had a heart attack and 20,000 healthy control individuals. Their results show that taking NSAIDs for less than a year does not increase the risk of heart attack. Regular NSAID use for longer than one year, however, can increase the risk of non-fatal heart attack by 20%. The authors analysed the heart attack risk associated with three of the most commonly used NSAIDs. Their results show that individual NSAIDs have different cardiovascular effects. Taking ibuprofen for over a year does not increase the risk of heart attack, while long-term diclofenac use causes a small increase in the risk of having a heart attack. Long-term use of naproxen could have a small protective effect according to this study.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
American Heart Association funds four new projects to evaluate the role of race in predicting heart disease risk